Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors

Annals of Indian Academy of Neurology

Volumn 12, Issue 3, 2009, Pages 162-166

  Shantaram, Manjula ^a   Rao, Anjali ^b   Aroor, Annaya Rao ^c   Raja, Annaswamy ^b   Rao, Suryanrayana ^b   Monteiro, Flama ^d  

^a YENEPOYA MEDICAL COLLEGE   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c UNIVERSITY OF MISSOURI   (United States)

^d Mandya Institute of Medical Sciences ^*  (India)

Author keywords

Brain tumors; Lipid bound sialic acid; Total sialic acid; Tumor markers

Indexed keywords

DIPHENYLAMINE; GLYCOCONJUGATE; PHOSPHOTUNGSTIC ACID; RESORCINOL; SIALIC ACID; TUMOR MARKER;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CEREBROSPINAL FLUID; CHILD; COLORIMETRY; COMPLEX FORMATION; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

EID: 70350123895     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.56315     Document Type: Article

References (30)

1. Warren L, Buck CA. The membrane glycoproteins of the malignant cell. Clin Biochem 1980;13:191-971.
2. Mali HR, Bhatt ML, Gupta JP, Singh MP. Serum sialic acid level: Possible role as a biomarker in head and neck cancer during radiotherapy. J Clin Radiother Oncol 1995;10:44-46
3. Zing RD, Chen RM, Wang ZS, Zhang YZ. Serum sialic acid levels in patients with oral and maxillofacial malignancy. J Oral Maxillofac Surg 1991;49:843-847
4. Aranganathan S, Senthil K, Nalini N. A case control study of glycoprotein status in ovarian carcinoma. Clin Biochem 2005;38:535-539
5. Gokmen SS , Kazezoglu C, Tabakoglu E, Altiay G, Gungor O, Ture M. Serum total sialic acid levels in lung cancer patients of different histological types with and no extrapulmonary metastases. Turkish J Biochem 2004;29:262-267
6. Verazin G, Riley WM, Gregory J, Tautu C, Prorok JJ, Alhadeff JA. Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer. Dis Colon Rectum 1990;33:139-142
7. Erbil KM, Sen SE, Zincke H, Jones JD. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies. Cancer 2006;57:1389-1394
8. Kazezodlu C, Gökmen SS, Sunar B, Aygõt C, Çakõr B. Serum total and lipid bound sialic acid levels in patients with benign and nonmelanom malignant skin tumors. Türk Biyokimya Dergisi 2007;31:17-21.
9. Monti M, Catania S, Locatelli E, Scazzoro A, Calzaferri A, Calzaferri G, et al. Sialic acid, ferritin and CEA levels in peripheral blood and blood drainage from the tumor in breast cancer. Int J Biol Markers 1988;3:243-248
10. Nakamura O, Ishihara E, Iwamori M, Nagai T, Matsutiani M, Nomura K, et al. Lipid composition of human malignant brain tumours. No-TShinkei 1987;39:221-226
11. Flaschka G, Marth E, Desoye G, Friedl W, Walzi M. Diagnostic value of biochemical tumour markers in brain tumours: Review of the literature and own experience with serum analysis of sialic acid (NANA), CEA and NSEJ. Zentralbl . Neurocher 1990;51:129-137
12. Marth E, Flaschka G, Steigler S, Mose JR. Sialic acid as a marker for differentiation between benign and malignant intracranial tumors. Clin Chim Acta 1988;176:251-258
13. Dnistrian AM, Skipski VP, Barclay M, Stock CC. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5123 Tc. Cancer Res 1977;37:2185-2187
14. Musset M, Mathe G, Reizenstein P. Serum LBSA as a tumoral marker in minimal residual tumors. Bull Soc Sci Med Grand Duche Luxemb 1989;126:17-20.
15. Wong Y, Neale E, Wong F, Shun W. Serum lipid-associated sialic acid levels in gynaecologic malignancies. Int J Gynaecol Cancer 1993;3:143-146
16. Dnistrian AM, Schwartz MK, Katopodis N, Fracchia AA, Stock CC. Serum lipid bound sialic acid in breast cancer. Cancer 2006;50:1815-1819
17. Oztokatli A, Ozkarde H, Ovül E, Erol D. The Significance of serum lipid-bound sialic acid in bladder tumours. Int Urol Nephrol 1992;24:125-129
18. Kiljanski J, Ambroziak M, Pachucki J, Jadewski K, Wiechno W, Stachlewska E, et al. Thyroid sialyltransferase mRNA level and activity are increased in Graves disease. Thyroid 2005;15:645-652
19. Kostic D, Buckheit R. Gangliosides in human brain tumors. Life Sci 1979;9:589-596
20. Kakari S, Avgoustatos G, Ferderigos AS, Poulaki E, Sakka P, Karamplianins A, et al. Total and lipid bound sialic acid in the cerebrospinal fluid of patients with brain tumours. Anticancer Res 1984;4:313-316
21. Winzler RJ. Methods of biochemical analysis. In: Glick D, editor. Vol 2. New York: Interscience Publishers Inc.; 1955. p. 279-377.
22. Katopodis N, Stock CC. Improved method to determine lipid bound sialic acid in plasma or serum. Res Commun Chem Pathol Pharmacol 1980;30:171-180
23. Regina Todeschini A, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 2008;1780:421-433
24. Hakomori S. Aberrant glycosylation in tumors and tumor- associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
25. Hakomori S Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid. Metabolism Cancer Res 1996;56:5309-18.
26. Fredman P, Von-Holst H, Collins VP, Ammar A, Delheden B, Wahren B, et al. Potential ganglioside antigens associated with human glioma. Neurol Res 1986;8:123-126
27. Dnistrian AM, Schwartz MK, Katopodis N, Fracchia AA, Stock CC. Serum lipid bound sialic acid as a marker in breast cancer. Cancer 1982;50:1815-1819
28. Stratton JA, Rettenmaier MA, Philips HB, Herabuttya S and Disaia PJ. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the status of patients with gynecologic malignancies. Obstet Gynecol 1988;71:20-26
29. O.Kennedy R, Berns G, Moran E, Smyth H, Carroll K, Thornes RD. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett 1991;58:91-100.
30. Deng W, Li, R, Ladisch S. Inß uence of cellular ganglioside, depletion on tumor formation. J Nat Cancer Inst 2000;92:912-917